NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

The company is has to address the investigation in every 10Q and K and financial filing, and with each filing, they do provide an update. The most recent one indicates that it is first winding to a conclusion. The SEC has also informed the company that their concerns about two things:

the Company's internal controls over financial reporting
and
the adequacy of certain disclosures made in the past

If the SEC never states that the investigation is concluded, I'd think NWBO would have to continue to carry it in their filings. And I don't think that would be fair, especially if the investigation were over. So I'd think they would finally arrive at a conclusion and state it. If it turns out to be nothing, then the company can state that it's over and done with. If there is something that requires addressing and the company is told what it is, then they can fix it, or pay for it, and then hopefully be through with it.

If the adequacy of certain disclosures concerns something material like the halt, then I wonder if the SEC is allowing the company to carry on as is, until perhaps the trial is unblinded and the reason for the halt is shared. Then the SEC would decide if they agreed or not with the company's decision to not address it as of this time.

Otherwise, it's hard to imagine what justifies the continuation of the investigation. I mean, it's been more than two years.